PLANO, Federica
 Distribuzione geografica
Continente #
EU - Europa 156
NA - Nord America 50
AS - Asia 44
SA - Sud America 18
AF - Africa 1
Totale 269
Nazione #
IT - Italia 118
US - Stati Uniti d'America 50
SG - Singapore 18
BR - Brasile 16
DE - Germania 15
CN - Cina 8
NL - Olanda 6
FI - Finlandia 5
GB - Regno Unito 4
HK - Hong Kong 4
IN - India 3
AT - Austria 2
PH - Filippine 2
TR - Turchia 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BO - Bolivia 1
FR - Francia 1
GR - Grecia 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
OM - Oman 1
PL - Polonia 1
PY - Paraguay 1
ZA - Sudafrica 1
Totale 269
Città #
Palermo 38
Singapore 13
Ashburn 10
Milan 9
Rome 9
The Dalles 8
Munich 5
Vicenza 5
Catania 4
Turin 4
Boardman 3
Cavallino 3
Corropoli 3
Helsinki 3
Nuremberg 3
Piscataway 3
Santa Clara 3
Sciara 3
Agrigento 2
Alcamo 2
Ankara 2
Caltanissetta 2
Clusone 2
Council Bluffs 2
Enfield 2
Hong Kong 2
Jundiaí 2
Lamezia Terme 2
Lappeenranta 2
Ludwigshafen am Rhein 2
Noto 2
Tashkent 2
Amman 1
Athens 1
Barletta 1
Beijing 1
Belém 1
Bengaluru 1
Binangonan 1
Bishkek 1
Bocaiúva 1
Brasília 1
Campo Bom 1
Campos dos Goytacazes 1
Canoas 1
Central 1
Ciudad del Este 1
Clementina 1
Colombo 1
Criciúma 1
Dublin 1
Florence 1
Hefei 1
Hounslow 1
Huilong 1
Johannesburg 1
La Paz 1
Los Angeles 1
Louveira 1
Manassas 1
Manila 1
Mumbai 1
Muscat 1
Osasco 1
Osório 1
Petaling Jaya 1
Porto Empedocle 1
Recife 1
Salt Lake City 1
Sanming 1
São Paulo 1
Varginha 1
Vienna 1
Wanchai 1
Washington 1
Zavet 1
Totale 201
Nome #
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again 94
Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome 83
A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab 33
Humoral and Cell-Mediated Responses to SARS-CoV-2 Vaccination in a Cohort of Immunodeficient Patients 30
Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients 28
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma 24
High TIM-3 Expression May Contribute to the Functional Impairment of Bone Marrow and Circulating Gamma Delta T Lymphocytes during the Progression of Multiple Myeloma 21
Totale 313
Categoria #
all - tutte 1.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202350 0 0 0 0 0 0 16 3 0 0 24 7
2023/2024106 3 19 10 11 3 13 7 8 3 3 10 16
2024/2025157 7 9 11 18 5 19 25 22 23 18 0 0
Totale 313